FDA Rejects Bid To Authorize Cheap Antidepressant As Covid Treatment

Fluvoxamine has been used to treat depression and obsessive-compulsive disorder for 15 years, but its usefulness as a Covid-19 treatment has yet to be proven, the Food and Drug Administration said.

Source: Forbes.com Healthcare News - May 16, 2022 Category: Pharmaceuticals Authors: Zachary Snowdon Smith, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Source Type: news